Skip to content

Clinical Study of the invigorating spleen to eliminate dampness Method in the Intervention of Acute Gastrointestinal Injury of Sepsis

Clinical Study of the invigorating spleen to eliminate dampness Method in the Intervention of Acute Gastrointestinal Injury of Sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000785
Enrollment
Unknown
Registered
2025-04-17
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Gastrointestinal Injury of Sepsis

Interventions

control group:fluid infusion
multiple organ support therapy
Nutrition support therapy etc
treatment group:Add modified Xiangsha Liujunzi combined with Pingwei Powder on the basis of the control group

Sponsors

Luzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Expected length of stay in ICU is = 7 daysConform to the diagnostic standards 2.AGI (Acute Gastrointestinal Injury) score grade I - III 3.Over 18 years old gender unlimited 4.APACHE II score = 15 5.It is expected that patients will start enteral nutrition within 48 hours including oral nutritional supplements and through nasogastric tubes or nasojejunal tubesor  gastrostomy/jejunostomy tubes. 6.The patient or their family member has given informed consent and is willing to accept this treatment plan.

Exclusion criteria

Exclusion criteria: 1.The expected length of stay in the ICU is less than 7 days 2.The primary disease is a gastrointestinal disorder such as peptic ulcer gastrointestinal bleeding gastric cancer mechanical intestinal obstruction etc 3.The Patient with AGI (Acute Gastrointestinal Injury) Grade IV 4.Woman during pregnancy 5.The patients with Severe cancer cachexiaor with opioid addiction 6.The patient's position is restricted and they are unable to cooperate with the ultrasound examination 7.The patient has a history of allergy to the traditional Chinese medicine drugs used in this study 8.Patients or their families who do not consent to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Enteral feeding calorie intake;The number of bowel sounds;antral contraction frequencyACF;Traditional Chinese Medicine (TCM) Syndrome Score;AcuteGastrointestinalinjury(AGI)classification;Gastric residual volume(GRV);

Secondary

MeasureTime frame
Procalcitonin (PCT);White blood cell count and percentage of neutrophils;Acute Physiology and Chronic Health Evaluation (APACHE-II);C-reactive protein (CRP);Sequential Organ Failure Assessment (SOFA) score;

Countries

China

Contacts

Public ContactHe Hongcai

Luzhou Traditional Chinese Medicine Hospital

1182671396@qq.com+8617345751167

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026